Compounding Pharmacy · Houston, TX · 503B
Wells Pharma of Houston Review
Wells Pharma of Houston is an FDA-registered 503B outsourcing facility in Houston, Texas that compounded sterile injectables including semaglutide and tirzepatide for clinics and providers during the GLP-1 shortage era. It received an FDA Form 483 in March 2025 and an FDA Warning Letter in November 2025 for sterility-assurance and 503B-compliance deficiencies. It is a separate legal entity from the Wells Pharmacy Network of Ocala, Florida.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Top-Rated GLP-1 Partners
Not sourced from Wells Pharma of Houston — these are our highest-scored vetted telehealth partners for compounded GLP-1s, if you'd rather start with a provider we've walked through end to end.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
No insurance needed · HSA/FSA eligible · vetted by our editors
Sunlight
Compounded GLP-1 with unlimited telehealth visits and free shipping
Starting price: $159/mo
Get started →Read review Sunlight →MadeMed
Compounded GLP-1 in both injection and oral forms
Starting price: $219/mo
Get started →Read review MadeMed →Breeze Meds
Compounded GLP-1 access with named prescribers and 4-pharmacy network
Starting price: $169/mo
Get started →Read review Breeze Meds →| Provider | Starting price | |
|---|---|---|
7.3Sunlight | $159/mo | Get started → |
7.4MadeMed | $219/mo | Get started → |
8.3Found | $99/mo | Get started → |
7.4Breeze Meds | $169/mo | Get started → |
Certifications & Compliance
All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.
Drugs Produced
Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].
States Licensed
Wells Pharma of Houston has not published a state-by-state licensure list. Verify licensure for your state directly with your state board of pharmacy before filling a prescription here.
Regulatory Actions
Weight Loss Rankings Score Breakdown
Scores are independently researched. See our methodology for details.
High confidence · Last verified 2026-06-04 via manual · How we verify provider data
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources & methodology — as of July 2026
- 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
- 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
- 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
- 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.